Etoposide 50mg Capsules - Origin: India

Etoposide 50mg is a chemotherapeutic drug widely used in the treatment of various cancers. It is a semisynthetic derivative of podophyllotoxin, and it belongs to the class of topoisomerase inhibitors, specifically targeting topoisomerase II.

Etoposide is used to treat several cancers, either as monotherapy or in combination regimens. Common indications include:

1. Small Cell Lung Cancer (SCLC):

   * Often part of first-line chemotherapy regimens (e.g., with cisplatin or carboplatin).

2. Testicular Cancer:

   * Typically combined with other agents like cisplatin and bleomycin for metastatic disease.

3. Hodgkins and Non-Hodgkins Lymphomas:

   * In relapsed or refractory cases.

4. Acute Myeloid Leukemia (AML):

   * As part of salvage chemotherapy regimens.

5. Ovarian Cancer, Kaposi Sarcoma, and Neuroblastoma:

   * In specific clinical scenarios.

Etoposide interferes withtopoisomerase II, an enzyme critical for DNA unwinding and replication. By stabilizing the enzyme-DNA complex during the re-ligation step:

1. It causesDNA strand breaks, preventing replication and transcription.
2. This leads tocell cycle arrest, predominantly in theSandG2 phases, and ultimately results in apoptosis.

1. The dosage depends on the specific cancer, patients condition, and treatment regimen.
2. Standard Dose (SCLC) :
   • 50-100 mg/m/dayfor 5 days, continue every 3 weeks.

1. Administered over 30-60 minutes to reduce the risk of hypotension.
2. Common dose :100-120 mg/m/dayfor 3-5 days.

1. Swallow capsules whole; do not crush or chew.
2. Take on an empty stomach, as food can reduce absorption.